Intravenus Cannulla Manufacturing Procedure

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 6

REVITAL HEALTH EPZ LIMITED

INTRAVENOUS CANNULA PROCEDURE

INTRAVENOUS CANNULA PROCEDURE

APPROVED BY
REVITAL HEALTH EPZ LIMITED
INTRAVENOUS CANNULA PROCEDURE
REVISIONS TABLE

REVISION REVISE DESCRIPTION DATE


NUMBER D
PAGE(S)
0 0 Original Issue 18/06/2018

1. PURPOSE:
REVITAL HEALTH EPZ LIMITED
INTRAVENOUS CANNULA PROCEDURE
To ensure that all the intravenous cannula with or without wings and with or without
injection port are manufactured in a safe manner and ensure they meet all legal
and regulatory requirements

2. SCOPE:

The procedure covers Blister, Packaging, Sterilization and Distribution of the


medical devices

3. DEFINITIONS AND ABBREVIATIONS:

I V – Intravenous- existing or taking place within, or administered into, a vein or


veins.

Sterilization: the process of making something free from bacteria or other living
microorganisms

Cannula- a thin tube inserted into a vein or body cavity to administer medication,
drain off fluid, or insert a surgical instrument.

4. RESPONSIBILITIES:

Production operator has the responsibility of carrying out the procedure as


prescribed.

Production Supervisor has the responsibility of ensuring that the procedure is


executed as per the requirements.

Production Manager has overall responsibility for effective implementation of this


procedure.

5. FLOWCHART:
PRODUCTION PROCESS FLOW CHART OF
I.V. CANNULA
Requisition of I.V. CANNULA
& packing Material etc.

I.V. Cannula &


Primary packaging
REVITAL HEALTH EPZ LIMITED
INTRAVENOUS CANNULA PROCEDURE

Batch Stamping

Accepted Rejected

Secondary Packing
Dispose

Tertiary/Box
packing

Bio-Burden
EO Gas
Sterilization

Microbiological
Quarantine
Tests (Sterility test)

Sterility test Report

Accepted Non Accepted

Send to Finished
Goods Store
6. PROCEDURE DESCRIPTION:

Blister / Packing
 Pack the device singularly in a hard blister film and a medical grade paper.
REVITAL HEALTH EPZ LIMITED
INTRAVENOUS CANNULA PROCEDURE
 At the packing area, pack in a secondary package of either 100 or 50 pieces.
 Finally pack into tertiary containers which are sealed ready or sterilization

Sterilization and Distribution

 Ensure you have Ethylene Oxide gas and carbon dioxide in the ration of 20:80.
 Stack the products on pallets in the quarantine area for 14days pending sterility
test.
(N/B Sterility of the device is vital)
 Ensure stringent measures are taken assure they are free from disease-causing
agents.
 After they pass the quality checks, release to the finished goods store for sale.

7. Quality Control

The quality of the components of these devices is checked during each phase of
manufacture. Consequently, Quality inspectors randomly check components at fixed time
intervals to ensure they meet size, shape, and consistency specifications. These random
samples give a good indication of the quality of the intravenous cannula produced. Visual
inspection is the primary test method. However, more rigorous measurements should also
be performed. Measuring equipment such as Vanier caliper, weighing scales, leakage
test machines, micro pipette, a micrometer should be used to check the length, width,
and thickness of the component pieces., Quality inspectors should be stationed at various
points of the production process and visually inspect the components as they are made.
Examples of nonconformities to check are: deformed IV Cannula components, leakage,
black spots, pieces that fit together incorrectly, or inappropriate packaging

8. ENVIRONMENTAL:

Intravenous cannula material wastes are non bio-degradable wastes and should be
disposed appropriately to ensure no negative effect on the environment.

9. OCCUPATIONAL HEALTH AND SAFETY:

. Proper training as well as awareness should be created to the person handling the
equipment. Safety signage is also good to portray for the safety of the operators running
the production equipment.

10. TRAINING:

To avoid contamination of devices great should be done to all associates involved in


implementing this procedure.
REVITAL HEALTH EPZ LIMITED
INTRAVENOUS CANNULA PROCEDURE
11. PREVENTIVE AND CORRECTIVE ACTION:

Incase this procedure is not successful or the expected results are not achieved then the
failure should be addressed through a corrective action approach as per the corrective
action procedure.

12. RECORD KEEPING:

Record (Title) Form No. Storage Location Retention Period

List of Reviewers:
Production operators
Quality Assurance Manager
Production Manager

Document Approval

Approval Level: CEO HOD X

Approver’s Name Approver’s Signature

You might also like